4.2 Article

Transplantation of Mesenchymal Stem Cells as a New Approach for Cardiovascular Diseases: From Bench to Bedside: A Perspective

Related references

Note: Only part of the references are listed.
Article Cell Biology

EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment

Xiaofan Zhang et al.

Summary: This article summarizes the characteristics of mesenchymal stem cells (MSCs), the latest progress in MSC research and its application prospects, and proposes some new ideas for the treatment of atherosclerosis by targeting MSCs in view of the process of endothelial-to-mesenchymal transition (EndMT) occurring in atherosclerosis.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)

Article Medicine, Research & Experimental

Single vs. double intracoronary injection o mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial

Armin Attar et al.

Summary: This study aims to compare the effect of single and double injection of MSCs on LVEF improvement after AMI. The study is conducted as a single-blind, randomized, multicenter trial, with the primary endpoint being the assessment of improvement in LVEF.

TRIALS (2022)

Article Cell & Tissue Engineering

Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trials

Alireza Hosseinpour et al.

Summary: This study compared the effects of transplantation of bone-marrow mononuclear cells (BM-MNCs) and mesenchymal stem cells (MSCs) on ejection fraction (LVEF) in patients with acute myocardial infarction (AMI). The results showed that both types of cells significantly improved LVEF in the short term, with MSCs being more effective according to the ICEMAN criteria. The effect was even more pronounced in patients who received stem cell transplantation in the early course after AMI.

STEM CELL RESEARCH & THERAPY (2022)

Review Cell Biology

Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease

Anthony Matta et al.

Summary: Transplantation of mesenchymal stem cells (MSCs) has shown good clinical outcomes in cardiovascular diseases such as heart failure, cardiomyopathy, and ischemic heart disease. This is attributed to reduced ventricular remodeling, myocardial fibrosis, scar size, and improved endothelial dysfunction. MSCs also exhibit regenerative, pro-angiogenic, anti-apoptotic, and anti-inflammatory effects. This review focuses on different preconditioning methods and novel approaches to optimize the efficacy of MSC therapy.

CELLS (2022)

Article Medicine, General & Internal

Wellens' Syndrome from COVID-19 Infection Assessed by Enhanced Transthoracic Coronary Echo Doppler: A Case Report

Carlo Caiati et al.

Summary: This case report describes how COVID-19 infection can cause Wellens' syndrome, and introduces the use of enhanced transthoracic coronary echo Doppler for bedside assessment. This method can be pivotal in distinguishing true Wellens' syndrome from pseudo-Wellens' syndrome.

DIAGNOSTICS (2022)

Article Cell & Tissue Engineering

Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up

Che Zhang et al.

Summary: This study evaluated the safety and efficacy of mesenchymal stem cell therapy for patients with DFU and PAD. Over 95% of patients achieved ulcer healing within 1.5 months post-treatment, and there were no cases of amputation due to recurrence within 3 years after treatment.

STEM CELL RESEARCH & THERAPY (2022)

Review Cell & Tissue Engineering

Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia

Zeinab Shirbaghaee et al.

Summary: This article reviews the immunomodulatory features of mesenchymal stem cells (MSCs) and their potential applications as therapeutic agents in the treatment of critical limb ischemia (CLI). Despite advances in clinical research, MSC therapy is still considered experimental and not recommended for regular clinical use. The article provides recommendations to improve the efficacy of cell therapy for CLI patients.

STEM CELL RESEARCH & THERAPY (2022)

Article Medicine, General & Internal

Hidden Coronary Atherosclerosis Assessment but Not Coronary Flow Reserve Helps to Explain the Slow Coronary Flow Phenomenon in Patients with Angiographically Normal Coronary Arteries

Carlo Caiati et al.

Summary: The slow coronary flow phenomenon (SCFph) is controversial in patients with normal angiographically coronary arteries. This study found that SCFph is strongly associated with epicardial atherosclerosis. A plaque burden of < 33% shows a high negative predictive value in ruling out SCFph.

DIAGNOSTICS (2022)

Review Medicine, General & Internal

Treatment of ischemic stroke with modified mesenchymal stem cells

Hao Chen et al.

Summary: Ischemic stroke is a major cause of death and disability, and mesenchymal stem cell (MSC) therapy holds promise as a treatment modality. However, the therapeutic effect of MSCs is limited in the harsh microenvironment of ischemic brain tissue. Modified MSC therapy has shown better outcomes under different pathological conditions, and is expected to be translated into clinical practice.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)

Article Cardiac & Cardiovascular Systems

High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease A Randomized Study

Jan Henzel et al.

Summary: The study aimed to investigate the impact of diet and lifestyle intervention on atherosclerotic plaque volume and composition. The results suggest that controlled diet and lifestyle intervention may slow the progression of atherosclerosis and reduce the volume of noncalcified plaque.

JACC-CARDIOVASCULAR IMAGING (2021)

Article Cell & Tissue Engineering

Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials

Armin Attar et al.

Summary: Research on the role of mesenchymal stem cells (MSCs) in increasing ejection fraction (LVEF) after acute myocardial infarction (AMI) has sparked some controversy. This study found that transplantation of MSCs after AMI significantly increases LVEF, with a more pronounced effect if done within the first week after the heart attack. Further studies are needed to investigate long-term clinical outcomes such as heart failure and cardiovascular mortality.

STEM CELL RESEARCH & THERAPY (2021)

Article Cardiac & Cardiovascular Systems

A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial

Roberto Bolli et al.

Summary: The CONCERT-HF trial demonstrated the safety and feasibility of CPCs and MSCs treatment in ischemic cardiomyopathy-induced heart failure patients, with CPCs reducing MACE and MSCs improving quality of life. Further investigation is warranted to explore the potential beneficial effects of these cell types in heart failure.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Review Cell & Tissue Engineering

Application of mesenchymal stem cell sheet to treatment of ischemic heart disease

Dehua Chang et al.

Summary: The review discusses the use of MSC sheets for improving cardiac function and alleviating adverse ventricular remodeling in ischemic heart tissue. Among various types of MSCs, UC-MSCs are highlighted as a promising candidate due to their unique features and ease of isolation and culture.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell Biology

miR-4732-3p in Extracellular Vesicles From Mesenchymal Stromal Cells Is Cardioprotective During Myocardial Ischemia

Rafael Sanchez-Sanchez et al.

Summary: Extracellular vesicles derived from mesenchymal stromal cells (MSCs) and containing miR-4732-3p microRNA show potential for cardioprotection, with miR-4732-3p being regulated by hypoxia and exerting protective actions against ischemic insult.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Cell Biology

Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives

Babak Arjmand et al.

Summary: Cardiovascular disease is the leading cause of adult death worldwide, with myocardial infarction accounting for four fifths of cardiovascular disease deaths. Regenerative medicine, particularly using stem cells to repair the heart, has shown promising benefits as a treatment for ischemic heart disease. Despite the potential of stem cell therapy, more research is needed to fully understand its mechanism of action and its long-term effects on cardiovascular disease.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Physiology

Mesenchymal stem cells protect renal tubular cells via TSG-6 regulating macrophage function and phenotype switching

Yu Zhao et al.

Summary: The study revealed that TSG-6 released from mesenchymal stem cells (MSCs) can alleviate renal tubular cell injury by regulating macrophage function and phenotype, providing renal protection in ischemic conditions.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Cardiac monocytes and macrophages after myocardial infarction

Claire Peet et al.

CARDIOVASCULAR RESEARCH (2020)

Review Biochemistry & Molecular Biology

Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia

Frantisek Jaluvka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cardiac & Cardiovascular Systems

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study

Gregory A. Roth et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Cell & Tissue Engineering

Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes

Maryam Farzaneh et al.

CURRENT STEM CELL RESEARCH & THERAPY (2019)

Article Medicine, General & Internal

Atherosclerosis

Peter Libby et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Editorial Material Cardiac & Cardiovascular Systems

Contrast-Enhanced Ultrasound Reveals That Lipoprotein Apheresis Improves Myocardial But Not Skeletal Muscle Perfusion

Carlo Caiati

JACC-CARDIOVASCULAR IMAGING (2019)

Review Hematology

Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients

Nigel Mackman et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Can We Engineer a Human Cardiac Patch for Therapy?

Jianyi Zhang et al.

CIRCULATION RESEARCH (2018)

Review Urology & Nephrology

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Yufang Shi et al.

NATURE REVIEWS NEPHROLOGY (2018)

Review Medical Laboratory Technology

Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction

Yonggang Ma et al.

TRANSLATIONAL RESEARCH (2018)

Editorial Material Cardiac & Cardiovascular Systems

Atherosclerosis A Chronic Inflammatory Disease With an Autoimmune Component

Kouji Kobiyama et al.

CIRCULATION RESEARCH (2018)

Review Cell & Tissue Engineering

Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs

Guanguan Qiu et al.

STEM CELL RESEARCH & THERAPY (2018)

Review Biotechnology & Applied Microbiology

Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction

Ayman El-Sayed Shafei et al.

JOURNAL OF GENE MEDICINE (2017)

Article Medicine, General & Internal

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

Steven E. Nissen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Biotechnology & Applied Microbiology

Optimization of genome editing through CRISPR-Cas9 engineering

Jian-Hua Zhang et al.

BIOENGINEERED (2016)

Review Cell & Tissue Engineering

Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?

Ann De Becker et al.

WORLD JOURNAL OF STEM CELLS (2016)

Article Medicine, General & Internal

Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy The TAC-HFT Randomized Trial

Alan W. Heldman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Biochemistry & Molecular Biology

Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages

Dong-Im Cho et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2014)

Article Cell & Tissue Engineering

Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies

Federica Casiraghi et al.

STEM CELL REVIEWS AND REPORTS (2013)

Review Pharmacology & Pharmacy

Cellular plasticity: the good, the bad, and the ugly? Microenvironmental influences on progenitor cell therapy

Jan-Renier A. J. Moonen et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)

Review Dentistry, Oral Surgery & Medicine

Interplay between Mesenchymal Stem Cells and Lymphocytes: Implications for Immunotherapy and Tissue Regeneration

L. Wang et al.

JOURNAL OF DENTAL RESEARCH (2012)

Article Cardiac & Cardiovascular Systems

Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product

Gabriel P. Lasala et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)

Article Cell & Tissue Engineering

Defining the risks of mesenchymal stromal cell therapy

Darwin J. Prockop et al.

CYTOTHERAPY (2010)

Article Cell & Tissue Engineering

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

Ruenn Chai Lai et al.

STEM CELL RESEARCH (2010)

Article Multidisciplinary Sciences

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity

Henry C. Quevedo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Cardiac & Cardiovascular Systems

HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation

R Ockaili et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)